Asker Healthcare Net Assets
Asker Healthcare net assets. Based on the latest financial reports, Asker Healthcare (ASKER) has net assets worth Skr7.02 Billion SEK (≈ $755.36 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr17.83 Billion ≈ $1.92 Billion USD) and total liabilities (Skr10.81 Billion ≈ $1.16 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ASKER shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr7.02 Billion |
| % of Total Assets | 39.36% |
| Annual Growth Rate | 37.93% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.89 |
Net Assets of Asker Healthcare (2021–2025)
Net assets of Asker Healthcare from 2021 to 2025. This chart illustrates how Asker Healthcare's net assets have evolved over time, based on quarterly financial data. See ASKER net asset quality score to measure how much of total assets are equity-financed.
Annual Net Assets for Asker Healthcare (2021–2025)
The table below shows the annual net assets of Asker Healthcare from 2021 to 2025. For live market cap and overall valuation, see market cap of Asker Healthcare.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr6.59 Billion ≈ $708.97 Million |
+88.12% |
| 2024-12-31 | Skr3.50 Billion ≈ $376.87 Million |
+15.16% |
| 2023-12-31 | Skr3.04 Billion ≈ $327.26 Million |
+8.96% |
| 2022-12-31 | Skr2.79 Billion ≈ $300.36 Million |
+53.35% |
| 2021-12-31 | Skr1.82 Billion ≈ $195.86 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Asker Healthcare's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 211.8% over the analyzed period, indicating profitable operations and earnings retention.
Asker Healthcare Net Assets Breakdown (December 2025)
Asker Healthcare net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr2.15 Billion | 32.72% |
| Common Stock | Skr1.00 Million | 0.02% |
| Other Comprehensive Income | Skr-26.00 Million | -0.40% |
| Other Components | Skr4.43 Billion | 67.66% |
| Total Equity | Skr6.55 Billion | 100.00% |
Asker Healthcare Competitors by Market Cap
The table below lists competitors of Asker Healthcare ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhefu Holding Group Co Ltd
SHE:002266
|
$2.88 Billion |
|
APERAM S.A. NY SHS/1 O.N.
F:7AAN
|
$2.88 Billion |
|
XINYI SOLAR UNSP.ADR/20
F:13X0
|
$2.88 Billion |
|
Escorts Kubota Limited
NSE:ESCORTS
|
$2.88 Billion |
|
El Al Israel Airlines Ltd
TA:ELAL
|
$2.88 Billion |
|
Chenzhou Jingui Silver Industry Co Ltd
SHE:002716
|
$2.88 Billion |
|
Callaway Golf Company
NYSE:CALY
|
$2.87 Billion |
|
China International Marine Containers (Group) Co. Ltd
F:OCM
|
$2.87 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Asker Healthcare's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,469,000,000 to 6,555,000,000, a change of 3,086,000,000 (89.0%).
- Net income of 492,000,000 contributed positively to equity growth.
- New share issuances of 1,407,000,000 increased equity.
- Other comprehensive income decreased equity by 272,000,000.
- Other factors increased equity by 1,459,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr492.00 Million | +7.51% |
| Share Issuances | Skr1.41 Billion | +21.46% |
| Other Comprehensive Income | Skr-272.00 Million | -4.15% |
| Other Changes | Skr1.46 Billion | +22.26% |
| Total Change | Skr- | 88.96% |
Book Value vs Market Value Analysis
This analysis compares Asker Healthcare's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.92x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 14.94x to 3.92x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | Skr4.68 | Skr69.85 | x |
| 2022-12-31 | Skr7.21 | Skr69.85 | x |
| 2023-12-31 | Skr7.89 | Skr69.85 | x |
| 2024-12-31 | Skr9.06 | Skr69.85 | x |
| 2025-12-31 | Skr17.80 | Skr69.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Asker Healthcare utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.51%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.93%
- • Asset Turnover: 1.00x
- • Equity Multiplier: 2.56x
- Recent ROE (7.51%) is below the historical average (13.25%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 26.07% | 4.99% | 1.27x | 4.11x | Skr287.90 Million |
| 2022 | 15.56% | 3.67% | 1.15x | 3.70x | Skr153.70 Million |
| 2023 | 6.72% | 1.51% | 1.19x | 3.75x | Skr-99.30 Million |
| 2024 | 10.38% | 2.40% | 1.15x | 3.78x | Skr13.10 Million |
| 2025 | 7.51% | 2.93% | 1.00x | 2.56x | Skr-163.50 Million |
Industry Comparison
This section compares Asker Healthcare's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $9,296,000,000
- Average return on equity (ROE) among peers: 0.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Asker Healthcare (ASKER) | Skr7.02 Billion | 26.07% | 1.54x | $2.88 Billion |
| Arjo AB (publ) (ARJO-B) | $9.30 Billion | 0.00% | 0.42x | $963.84 Million |
About Asker Healthcare
Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating roo… Read more